Protective effects of resveratrol on glutamate-induced damages in murine brain cultures

Journal of Neural Transmission

Volumn 120, Issue 9, 2013, Pages 1271-1280

  Moldzio, Rudolf ^a   Radad, Khaled ^b   Krewenka, Christopher ^a   Kranner, Barbara ^a   Duvigneau, Johanna Catharina ^a   Rausch, Wolf Dieter ^a  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^b Assiut University   (Egypt)

Author keywords

Cell culture; Glutamate; Iron; Parkinson's disease; Resveratrol

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; GLUTAMIC ACID; RESVERATROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN CELL; BRAIN DAMAGE; CONTROLLED STUDY; CULTURAL ANTHROPOLOGY; DOPAMINERGIC NERVE CELL; DRUG EFFECT; FEMALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIOXIDANTS; BIPHENYL COMPOUNDS; BRAIN; CELLS, CULTURED; COLORING AGENTS; COPPER; ETHIDIUM; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; FLUORESCENT DYES; GLUTAMIC ACID; IRON; MESENCEPHALON; MICE; MICE, INBRED C57BL; NEURITES; NEURONS; ORGAN CULTURE TECHNIQUES; PICRATES; PREGNANCY; PROPIDIUM; SPECTROPHOTOMETRY, ATOMIC; STILBENES; TETRAZOLIUM SALTS; THIAZOLES; TYROSINE 3-MONOOXYGENASE;

EID: 84883462956     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-013-1000-6     Document Type: Article

References (44)

1. + neurotoxicity in mice. Neurochem Res 26:59-64
2. Belguendouz L, Fremont L, Linard A (1997) Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins. Biochem Pharmacol 53:1347-1355
3. Blanchet J, Longpré F, Bureau G, Morissette M, Dipaolo T, Bronchti G, Martinoli MG (2008) Resveratrol, a red wine polyphenol, protects dopaminergic neurons in MPTP treated mice. Prog Neuropsychopharmacol Biol Psychiatry 32:1243-1250
4. +-induced oxidative stress act by modulating markers of apoptotic death in dopaminergic neurons. Cell Mol Neurobiol 29:1169-1180
5. Chang Y, Wang S (2009) Inhibitory effect of glutamate release from rat cerebrocortical nerve terminals by resveratrol. Neurochem Int 54:135-141
6. Chung IM, Yeo MA, Kim SJ, Moon HI (2011) Neuroprotective effects of resveratrol derivatives from the roots of Vitis thunbergii var. sinuate against glutamate-induced neurotoxicity in primary cultured rat cortical cells. Hum Exp Toxicol 30:1404-1408
7. de Almeida LM, Piñeiro CC, Leite MC, Brolese G, Tramontina F, Feoli AM, Gottfried C, Gonçalves CA (2007) Resveratrol increases glutamate uptake, glutathione content, and S100B secretion in cortical astrocyte cultures. Cell Mol Neurobiol 27:661-668
8. Forth W, Henschler D, Rummel W, Starke K (1996) Allgemeine und spezielle pharmakologie und toxikologie, 7th edn. Spektrum Akad, Berlin
9. Frank L, Diemer NH, Kaiser F, Sheardown M, Rasmussen LS, Kristensen P (1995) Unchanged balance between levels of mRNA encoding AMPA glutamate receptor subtypes following global cerebral ischemia in the rat. Acta Neurol Scand 92:337-343
10. Franke H, Schelhorn N, Illes P (2003) Dopaminergic neurons develop axonal projections to their target areas in organotypic co-cultures of the ventral mesencephalon and the striatum/prefrontal cortex. Neurochem Int 42:431-439
11. Fukui M, Choi HJ, Zhu BT (2010) Mechanism for the protective effect of resveratrol against oxidative stress-induced neuronal death. Free Radic Biol Med 49:800-813
12. Gao ZB, Chen XQ, Hu GY (2006) Inhibition of excitatory synaptic transmission by trans-resveratrol in rat hippocampus. Brain Res 1111:41-47
13. Gille G, Rausch WD, Hung ST, Moldzio R, Ngyuen A, Janetzky B, Engfer A, Reichmann H (2002) Protection of dopaminergic neurons in primary culture by lisuride. J Neural Transm 109:157-169
14. Had-Aissouni L, Re DB, Nieoullon A, Kerkerian-Le Goff L (2002) Importance of astrocytic inactivation of synaptically released glutamate for cell survival in the central nervous system - are astrocytes vulnerable to low intracellular glutamate concentrations? J Physiol Paris 96:317-322
15. Jin F, Wu Q, Lu YF, Gong QH, Shi JS (2008) Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats. Eur J Pharmacol 600:78-82
16. Kopp P (1998) Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'? Eur J Endocrinol 138:619-620
17. Kuzuhara S, Mori H, Izumiyama N, Yoshimura M, Ihara Y (1988) Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study. Acta Neuropathol (Berl) 75:345-353
18. Lee SR, Im KJ, Suh SI, Jung JG (2003) Protective effect of green tea polyphenol (-)-epigallocatechin gallate and other antioxidants on lipid peroxidation in gerbil brain homogenates. Phytother Res 17:206-209
19. Lee MK, Kang SJ, Poncz M, Song KJ, Park KS (2007) Resveratrol protects SH-SY5Y neuroblastoma cells from apoptosis induced by dopamine. Exp Mol Med 39:376-384
20. Mandel S, Weinreb O, Reznichenko L, Kalfon L, Amit T (2006) Green tea catechins as brain-permeable, non toxic iron chelators to "iron out iron" from the brain. J Neural Transm Suppl 71:249-257
21. Marques FZ, Markus MA, Morris BJ (2009) Resveratrol: cellular actions of a potent natural chemical that confers a diversity of health benefits. Int J Biochem Cell Biol 41:5-8
22. Miyazaki I, Asanuma M, Diaz-Corrales FJ, Miyoshi K, Ogawa N (2004) Direct evidence for expression of dopamine receptors in astrocytes from basal ganglia. Brain Res 1029:120-123
23. Mokni M, Elkahoui S, Limam F, Amri M, Aouani E (2007) Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat. Neurochem Res 32:981-987
24. Moldzio R, Radad K, Duvigneau JC, Kranner B, Krewenka C, Piskernik C, Rausch WD (2006) Glutamate-induced cell death and formation of radicals can be reduced by lisuride in mesencephalic primary cell culture. J. Neural Transm 113(9):1095-1105
25. Oka A, Belliveau MJ, Rosenberg PA, Volpe JJ (1993) Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention. J Neurosci 13:1441-1453
26. Olanow CW, Tatton WG (1999) Etiology and pathogenesis of Parkinson's disease. Ann Rev Neurosci 22:123-144
27. Paris I, Dagnino-Subiabre A, Marcelain K, Bennett LB, Caviedes P, Caviedes R, Azar CO, Segura-Aguilar J (2001) Copper neurotoxicity is dependent on dopamine-mediated copper uptake and one-electron reduction of aminochrome in a rat substantia nigra neuronal cell line. J Neurochem 77:519-529
28. 2+-permeable AMPA receptors in neurological disorders. TINS 20:464-470
29. Plaitakis A, Shashidharan P (2000) Glutamate transport and metabolism in dopaminergic neurons of substantia nigra: implications for the pathogenesis of Parkinson's disease. J Neurol 247(Suppl. 2):II 25-II 35
30. Pollanen MS, Dickson DW, Bergeron C (1993) Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 52:183-191
31. Riederer P, Reichmann H, Janetzky B, Sian J, Lesch KP, Lange KW, Double KL, Nagatsu T, Gerlach M (2001) Neural degeneration in Parkinson's disease. Adv Neurol 86:125-136
32. Rodriguez MC, Obeso JA, Olanow CW (1998) Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection. Ann Neurol 44(Suppl 1):S175-S188
33. Shanker G, Aschner M (2001) Identification and characterization of uptake systems for cystine and cysteine in cultured astrocytes and neurons: evidence for methylmercury-targeted disruption of astrocyte transport. J Neurosci Res 66:998-1002
34. Sherer TB, Betarbet R, Greenamyre JT (2002) Environment, mitochondria and Parkinson's disease. Neuroscientist 8:192-197
35. Stanika RI, Pivovarova NB, Brantner CA, Watts CA, Winters CA, Andrews SB (2009) Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity. Proc Natl Acad Sci USA 10:9854-9859
36. --transport. Brain Res 610:69-74
37. Sun AY, Wang Q, Simonyi A, Sun GY (2008) Botanical phenolics and brain health. Neuromol Med 10:259-274
38. Vidavalur R, Otani H, Singal PK, Maulik N (2006) Significance of wine and resveratrol in cardiovascular disease: French paradox revisited. Exp Clin Cardiol 11:217-225
39. Virgili M, Contestabile A (2000) Partial neuroprotection of in vivo excitotoxic brain damage by chronic administration of the red wine antioxidant agent, trans-resveratrol in rats. Neurosci Lett 281:123-126
40. Wang XS, Ong WY, Connor JR (2002) Increase in ferric and ferrous iron in the rat hippocampus with time after kainate-induced excitotoxic injury. Exp Brain Res 143:137-148
41. Wang Q, Yu S, Simonyi A, Rottinghaus G, Sun GY, Sun AY (2004) Resveratrol protects against neurotoxicity induced by kainic acid. Neurochem Res 29:2105-2112
42. +: selective vulnerability of cultured mouse astrocytes. Brain Res 836:237-244
43. Yu AC, Yl Lee, Eng LF (1992) Glutamate as an energy substrate for neuronal-astrocytic interactions. Prog Brain Res 94:251-259
44. Zini R, Morin C, Bertelli A, Bertelli AA, Tillement JP (1999) Effects of resveratrol on the rat brain respiratory chain. Drugs Exp Clin Res 25:87-97